This resource describes how state health departments and other public health organizations can partner with people with HIV and/or who use(d) drugs in programmatic and policy making processes and evaluation.
Breadcrumb
- Home
- Resources and Tools
Resources and Tools
Harm reduction strategies and tools should be accessible to everyone – regardless of location, time, and/or experience.
This publication describes the recent trends of drug overdose deaths in the United States (U.S.) and the benefits of adopting harm reduction approaches.
Individuals who have HIV who also use drugs experience increased age-matched morbidity and mortality in comparison with those with HIV who do not use drugs.
This CDC report provides updated data related to HIV prevalence among people who inject drugs, documenting findings that underscore the need for low-barrier access to comprehensive and integrated needs-based syringe service programs for necessary prevention and
This PowerPoint slide deck reviews the foundations of harm reduction philosophy and practice, summarizes drug user health issues and trends, and aims to increase cultural competence and humility when working with people who use drugs.
In Los Angeles, New York, Houston, Philadelphia, and Washington, D.C., a National Institutes of Health funded clinical trial, known as INTEGRA, is evaluating the efficacy of delivering integrated HIV and substance use disorder care via mobile clinics.
Transgender people and communities, including nonbinary people, have specific needs within harm reduction programs.
This report analyzes the issues and trends underlying the syndemics of HIV, SUD, and viral hepatitis in West Virginia.
This document provides a quick overview of the federal discretionary funding programs that support essential aspects of the nation’s HIV response.
Pagination
- Page 1
- Next page ››